![ReHydration Adenosinum cyclophosphoricum, Coffea cruda, Glandula suprarenalis suis, Hypothalamus, Kali phos, Nat mur, Sarsaparilla, Silicea, Taraxacum, Thyroidinum 12 [hp_X]/118.2mL; 9 [hp_X]/118.2mL; 9 [hp_X]/118.2mL; 12 [hp_X]/118.2mL; 6 [hp_X]/118.2mL; 8 [hp_X]/118.2mL Liquid, 118.2 mL — NDC 64578-0175-01 package photo](https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9b532a31-530a-44f9-843f-f395a3e460b8&name=ReHydration+4oz++Label+Image+r02-25+03093.jpg)
ReHydration Adenosinum cyclophosphoricum, Coffea cruda, Glandula suprarenalis suis, Hypothalamus, Kali phos, Nat mur, Sarsaparilla, Silicea, Taraxacum, Thyroidinum 12 [hp_X]/118.2mL; 9 [hp_X]/118.2mL; 9 [hp_X]/118.2mL; 12 [hp_X]/118.2mL; 6 [hp_X]/118.2mL; 8 [hp_X]/118.2mL Liquid, 118.2 mL
by Energetix Corporation · 118.2 mL in 1 BOTTLE (64578-0175-1)
NDC 64578-0175-01
🏷️ FDA NDC (as labeled)
64578-0175-1
billing pads the package segment with a zero
OTC
On market
Non-controlled
🗂️ Data synced Sep 17, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
64578-0175-1
Product NDC
64578-0175
11-digit billing NDC
64578017501
UNII
E0399OZS9N, 3SW678MX72, 398IYQ16YV, S6G2NLH4Y7, CI71S98N1Z, 451W47IQ8X +4 more
SPL Set ID
9b532a31-530a-44f9-843f-f395a3e460b8
Established class (EPC)
Non-Standardized Food Allergenic Extract; Non-Standardized Plant Allergenic Extract
Physiologic effect
Increased Histamine Release; Cell-mediated Immunity
Chemical class
Allergens; Dietary Proteins; Plant Proteins; Seed Storage Proteins
DEA schedule
Non-controlled
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2023-03-24
Route
ORAL
Dosage form
LIQUID
Substance
ADENOSINE CYCLIC PHOSPHATE; ARABICA COFFEE BEAN; SUS SCROFA ADRENAL GLAND; BOS TAURUS HYPOTHALAMUS; DIBASIC POTASSIUM PHOSPHATE; SODIUM CHLORIDE; SARSAPARILLA; SILICON DIOXIDE; TARAXACUM OFFICINALE ROOT; THYROID, UNSPECIFIED
Why two NDCs?
The FDA registers this code as 64578-0175-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 64578-0175-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏭 Manufacturer & labeler
LabelerEnergetix Corporation
Labeler code64578
First marketedMar 2023
Product typeHuman Otc Drug
Portfolio49 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
🧪 What is this product?
ReHydration Adenosinum cyclophosphoricum is a homeopathic liquid product taken by mouth. It contains multiple homeopathic ingredients including plant extracts like coffee and taraxacum (dandelion), mineral salts, and animal-derived substances. In homeopathic practice, these ingredients are traditionally used to support various body functions, though homeopathic products are not evaluated by the FDA for safety or effectiveness. This product is marketed based on homeopathic tradition rather than clinical evidence.
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Adenosinum cyclophosphoricum, Coffea cruda, Glandula suprarenalis suis, Hypothalamus, Kali phos, Nat mur, Sarsaparilla, Silicea, Taraxacum, Thyroidinum?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 3K9958V90M
A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
-
UNII PDC6A3C0OX
Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
3 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statesInactive ingredients Alcohol, Vegetable Glycerin, Purified Water.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| ReHydration 12 [hp_X]/118.2mL; 9 [hp_X]/118.2mL; 9 [hp_X]/118.2mL; 12 [hp_X]/118.2mL; 6 [hp_X]/118.2mL; 8 [hp_X]/118.2mL 64578-0155-01 | Energetix | 118.2 ml | — | — | FDA listed | — |
| ReHydration 12 [hp_X]/118.2mL; 9 [hp_X]/118.2mL; 9 [hp_X]/118.2mL; 12 [hp_X]/118.2mL; 6 [hp_X]/118.2mL; 8 [hp_X]/118.2mLthis 64578-0175-01 | Energetix | 118.2 ml | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2023
On the market since
Mar 2023
📍
2026
Currently FDA-listed
3 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for ReHydration (this brand).
Top reported reactions
Reporter sex
Male · 38%
Female · 63%
Serious outcomes
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 64578-0175-01 You're viewing this | 118.2 mL in 1 BOTTLE (64578-0175-1) | 2023-03-24 | Active |
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
Homeopathic listing
About homeopathic listings
ReHydration Adenosinum cyclophosphoricum, Coffea cruda, Glandula suprarenalis suis, Hypothalamus, Kali phos, Nat mur, Sarsaparilla, Silicea, Taraxacum, Thyroidinum 12 [hp_X]/118.2mL; 9 [hp_X]/118.2mL; 9 [hp_X]/118.2mL; 12 [hp_X]/118.2mL; 6 [hp_X]/118.2mL; 8 [hp_X]/118.2mL LIQUID is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 64578-0175-1, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 64578-0175-01, written without dashes as 64578017501. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 64578-0175-01, the first segment (64578) is the labeler code FDA assigned to Energetix Corporation; the middle segment (0175) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Energetix Corporation. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Energetix Corporation is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses Temporary relief of increased or decreased thirst, dryness, headaches.
⏱️ Dosage and Administration ▾
Directions • MUST BE ADDED TO LIQUID. Add 15 drops per liter of water or as directed by a healthcare professional. Shake well before use. • Consult a physician for use in children under 12 years of age or if symptoms worsen or persist.
⚠️ Warnings ▾
Warnings • In case of overdose, get medical help or contact a Poison Control Center right away. • If pregnant or breast-feeding, ask a healthcare professional before use. • Keep out of reach of children.
🧪 Active Ingredient ▾
Active ingredients 118.2 mL contains 4% of Adenosinum cyclophosphoricum 12X, 30X; Coffea cruda 9X; Glandula suprarenalis suis 9X, 12X, 6C; Hypothalamus 12X, 6C, 12C; Kali phos 6X, 12X, 30X; Nat mur 8X, 12X, 30X; Sarsaparilla 4X, 6X, 12X, 6C; Silicea 12X, 30X; Taraxacum 4X; Throidnium 12X, 6C, 12C. Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
🧪 Inactive Ingredients ▾
Inactive ingredients Alcohol, Vegetable Glycerin, Purified Water.
🎯 Purpose ▾
Purpose Temporary relief of increased or decreased thirst, dryness, headaches.
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.